Related Experiment Video
Updated: Apr 26, 2026

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity
Gregory J Baker1, Peter Chockley1, Viveka Nand Yadav1
1Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, Michigan. Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, Michigan.
Abstract:
Natural killer (NK) cells safeguard against early tumor formation by destroying transformed target cells in a process referred to as NK immune surveillance. However, the immune escape mechanisms used by malignant brain tumors to subvert this innate type of immune surveillance remain unclear. Here we show that malignant glioma cells suppress NK immune surveillance by overexpressing the β-galactoside-binding lectin galectin-1. Conversely, galectin-1-deficient glioma cells could be eradicated by host NK cells before the initiation of an antitumor T-cell response. In vitro experiments demonstrated that galectin-1-deficient GL26-Cit glioma cells are ∼3-fold more sensitive to NK-mediated tumor lysis than galectin-1-expressing cells. Our findings suggest that galectin-1 suppression in human glioma could improve patient survival by restoring NK immune surveillance that can eradicate glioma cells. Cancer Res; 74(18); 5079-90. ©2014 AACR.
Insights
Malignant glioma cells evade natural killer (NK) cell immune surveillance by overexpressing galectin-1. Suppressing galectin-1 restores NK cell activity, enabling the eradication of glioma cells and potentially improving patient survival.
Area of Science:
- Immunology
- Oncology
- Neuro-oncology
Background:
- Natural killer (NK) cells are crucial for innate immunity, eliminating early tumor formations via immune surveillance.
- Malignant brain tumors, specifically gliomas, employ immune escape mechanisms to evade NK cell surveillance, but these are not fully understood.
Purpose of the Study:
- To investigate the role of galectin-1 in glioma immune escape from NK cell surveillance.
- To determine if targeting galectin-1 can restore NK cell-mediated glioma elimination.
Main Methods:
- Overexpression of galectin-1 in malignant glioma cells.
- Comparison of NK cell-mediated lysis of galectin-1-expressing versus galectin-1-deficient glioma cells in vitro.
- Assessment of galectin-1-deficient glioma cell eradication by host NK cells.
Main Results:
- Malignant glioma cells suppress NK immune surveillance through galectin-1 overexpression.
- Galectin-1-deficient glioma cells are significantly more sensitive (approximately 3-fold) to NK-mediated lysis.
- Host NK cells can eradicate galectin-1-deficient glioma cells before T-cell responses are initiated.
Conclusions:
- Galectin-1 is a key factor in glioma immune evasion by suppressing NK cell surveillance.
- Reducing galectin-1 expression in human glioma may restore NK immune surveillance and enhance tumor cell eradication.
- Targeting galectin-1 presents a potential therapeutic strategy to improve survival in glioma patients.
More Related Videos
Related Concept Videos
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Tumor Immunotherapy

